IP Library Granted Patent US 10,000,783
Granted Patent B2
US 10,000,783 · App. 14/383,698 · Granted Jun 19, 2018

Steviol glucosyltransferases and genes encoding the same

Inventors: Eiichiro Ono (Osaka, JP); Misa Ochiai (Osaka, JP)
Assignee: SUNTORY HOLDINGS LIMITED
C12P19/56A23L27/36A23L33/13A61K8/602A61Q19/00C07H1/00C07H15/256C07H21/00C12N9/1051A23V2002/00A61K2800/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,000,783
App. No.
14/383,698
Granted
Jun 19, 2018
Kind
B2
Abstract

Steviol glucosyltransferases and methods for producing steviol glycosides using the enzymes are provided. The present invention provides steviol glucosyltransferases and methods for producing steviol glycosides using the enzymes. The invention also provides transformants into which steviol glucosyltransferase genes are introduced and methods for preparing the transformants.

Claims (16)

1. An expression vector comprising a heterologous expression control region and a polynucleotide according to any one selected from (a) to (d) below:

(a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1;

(b) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2;

(c) a polynucleotide having at least 99% sequence identity with the full length of the nucleotide sequence of SEQ ID NO: 1, and having an activity of adding a sugar molecule to the glucose at position 13 of a compound represented by general formula (I) below; and

(d) a polynucleotide encoding a protein having an amino acid sequence having at least 99% sequence identity with the full length of the amino acid sequence of SEQ ID NO: 2, and having an activity of adding a sugar molecule to the glucose at position 13 of a compound represented by general formula (I) below:

wherein, R 1 represents H, a C 1 -C 20 alkyl, a C 2 -C 20 alkenyl, a C 2 -C 20 alkynyl, a C 4 -C 20 alkyldienyl, a C 6 -C 18 aryl, a C 6 -C 20 alkylaryl, a C 6 -C 20 arylalkyl, a C 4 -C 20 cycloalkyl, a C 4 -C 20 cycloalkenyl, a (C 3 -C 10 cycloalkyl) C 1 -C 10 alkyl, or a sugar residue.

2. The expression vector according to claim 1 , wherein the sugar molecule is a hexose.

3. The expression vector according to claim 1 , wherein the sugar molecule is one selected from glucose, mannose, and galactose.

4. The expression vector according to claim 1 , wherein said R 1 is H or the sugar residue which is a glucose monomer or a glucose dimer.

5. The expression vector according to claim 1 , wherein the compound is steviolmonoside or rubusoside.

6. A non-human transformant, into which the expression vector according to claim 1 is introduced.

7. The transformant according to claim 6 , which is a plant.

8. A method for producing a steviol glycoside, which comprises producing the steviol glycoside with the non-human transformant according to claim 6 .

9. The method according to claim 8 , wherein the steviol glycoside is steviolbioside, stevioside, rebaudioside A, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside F, or a combination thereof.

10. The method according to claim 8 , wherein the steviol glycoside is steviolbioside, rebaudioside A, stevioside, or rebaudioside B.

11. The method according to claim 8 , wherein the steviol glycoside is steviolbioside or stevioside.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2014
From: ONO, EIICHIRO; OCHIAI, MISA
To: SUNTORY HOLDINGS LIMITED
Reel/Frame 033690/0455 →
Priority Claims (1)
JP 2012-060473 · Mar 16, 2012 · national
Continuity (1)
Related Publication 20150159188A1 · Jun 11, 2015
Cited By (1)
US 12,371,677